Jeremy L. Stigall - 06 Mar 2023 Form 4 Insider Report for ClearPoint Neuro, Inc. (CLPT)

Role: GM, Biologics & Drug Delivery
Signature: /s/ Richard F. Mattern by Power of Attorney for Jeremy L. Stigall
Issuer symbol: CLPT
Transactions as of: 06 Mar 2023
Net transactions value: $0
Form type: 4
Filing time: 08 Mar 2023, 15:51:36 UTC
Previous filing: 23 Feb 2023
Next filing: 13 Jun 2023
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CLPT	Stock Option (Right to Buy)	Award	$0	+14,814		$0.000000	14,814	06 Mar 2023	Common Stock	14,814	$8.10	Direct	F1
transaction	CLPT	Restricted Stock Units	Award	$0	+44,444		$0.000000	44,444	06 Mar 2023	Common Stock	44,444		Direct	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares subject to this option vest as follows: (i) 20% of the total shares on the first anniversary of the grant date; (ii) 40% of the total shares on the second anniversary of the grant date; and (iii) 40% of the total shares on the third anniversary of the grant date.
F2	Each restricted stock unit represents a contingent right to receive one share of CLPT common stock.
F3	The restricted stock units vest as follows: (i) 20% of the total shares on the first anniversary of the grant date; (ii) 40% of the total shares on the second anniversary of the grant date; and (iii) 40% of the total shares on the third anniversary of the grant date.